iScience, 2025
Inflammation and dyslipidaemia in combined diabetes and tuberculosis; a cohort study

Brake J., Ajie M., Sumpter N. et al.

PLOS One, 2025
Serum IL-6 and PTX3 predict severe outcome from COVID-19 in ambulatory subjects: Impact for future therapeutic decisions

Poorbaugh J., Sims J., Zhang L. et al.

eBioMedicine, 2025
Radiomic and proteomic signatures of body mass index on brain ageing and Alzheimer's-like patterns of brain atrophy

Anagnostakis F., Kokkorakis M., Walker K. et al.

Diabetology & Metabolic Syndrome, 2025
Spontaneous brain activity in patients with type 2 diabetes: linking serum neuroproteins to cognitive ability

Zhang Z., Wang W., Yang X. et al.

International Journal of Biological Macromolecules, 2025
Causal relationship between 91 circulating inflammatory proteins and gynecological diseases: A two-sample bidirectional Mendelian randomization study

Wang J., Zhang P., Yuan J. et al.

Advanced Science, 2025
Colorectal Cancer Cells–Derived Exosomal PIK3CA Mutation DNA Promotes Tumor Metastasis by Activating Fibroblast and Affecting Tumor Metastatic Microenvironment

Wang R., Li W., Lv Y. et al.

Obesity Surgery, 2025
Changes in Inflammatory Markers Following Bariatric Surgery and the Impact of the Surgical Procedure: A 12-Month Longitudinal Study

Jensen R., Thuesen A., Huang Y. et al.

Scientific Reports, 2025
Plasma inflammation-related proteins associated with anxiety and depression disorders in IBD patients

Zhou M., Zhang W., Dang Y. et al.

Liver Cancer, 2025
Camrelizumab combined with Lenvatinib and RALOX-HAIC for unresectable hepatocellular carcinoma (Cal Era): a prospective, single-arm, phase II trial

Zang M., Li Q., Hu X. et al.

Nature Communications, 2025
Multi-organ metabolome biological age implicates cardiometabolic conditions and mortality risk

Zalesky A., Tian Y., Ferrucci L. et al.

Thrombosis Journal, 2025
Therapeutic targets for venous thromboemblism: proteome-wide mendelian randomization and colocalization analyses

Li X., Yang C., Zhou M. et al.

Infection, 2025
Antigen-specific chemokine CCL3 as a biomarker for distinguishing between recent and remote tuberculosis infection

Chang C., Ma Z., Ren W. et al.

Journal of Inflammation Research, 2025
Using Olink Proteomics to Identify Inflammatory Biomarkers in the Cerebrospinal Fluid in Guillain-Barré Syndrome

Sun S., Li M., Song J. et al.

Molecular Oncology, 2025
Systematic profiling of cancer‐fibroblast interactions reveals drug combinations in ovarian cancer

Gudoityte G., Sharma O., Leuenberger L. et al.

International Journal of Cardiology Cardiovascular Risk and Prevention, 2025
Circulating protein biomarkers and their association with vulnerable plaque characteristics – a PROSPECT II substudy

Sharma T., Maehara A., Maeng M. et al.

Journal of Cardiac Failure, 2025
The Association between Serially Measured Circulating Biomarker Patterns and Pulmonary Artery Pressures measured by Invasive Hemodynamic Monitoring

de Jong M., Allach Y., Kamar S. et al.

Med, 2025
Pre-treatment untargeted cerebrospinal fluid metabolomic profiling in tuberculous meningitis uncovers pathways associated with mortality

Le T., van Abeelen K., Ardiansyah E. et al.

Nature Communications, 2025
The health impacts and genetic architecture of food liking in cardio-metabolic diseases

Jiang W., Wang H., Geng Y. et al.

Signal Transduction and Targeted Therapy, 2025
Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study

Xie M., Bao M., Dong X. et al.

European Neuropsychopharmacology, 2025
Predicted plasma proteomics from genetic scores and treatment outcomes in major depression: a meta-analysis

Oliva V., Possidente C., Fanelli G. et al.